A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

In a news release, Guthrie, the comitteee chair, heralded the committee’s plan, (which also cuts in green energy and other ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Results of a real-world study that included people with hemophilia from 33 countries show that people with hemophilia B, ...

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

Immune checkpoint inhibitors, such as Opdivo (nivolumab) and Keytruda (pembrolizumab), have been a huge advance in the ...

A new law in Iowa, if signed by the governor, will mandate 100% pass-through of rebates, increased financial transparency, ...

Alli Oakes, executive director of research at Trilliant Health, shared that upcoding is a “prime example” of healthcare waste ...

Recently reported results from an open-label extension trial show positive safety and efficacy results after 52 weeks of use ...

Muscle weakness has the biggest impact on patients’ ability to walk, but other factors matter too, researchers found.

Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same ...